Sofar S P Ais An Italian Pharmaceutical Company Established In 1968Focusing On The Researchproductionand Marketing Of Pharmaceutical Productsmedical Devicesand Dietary Supplementsthe Company Is Headquartered In Italy And Reported A Turnover Of A 110 Million In 2021Reflecting A Year Over Year Growth Of 7 18 Sofar Offers A Diverse Range Of Productsparticularly In Gastroenterologyand Has Over 150 Product References Across More Than 10 Therapeutic Areas In October 2022Sofar Was Acquired By Alfasigma S P A Which Aims To Enhance Its Product Portfolio And Expand Its Global Reachfollowing The Acquisitionsofar S Products Are Distributed In Over 10 Countriesbenefiting From Alfasigma S Extensive Networkthe Company Is Committed To Serving Healthcare Professionals And Patientsparticularly In The Field Of Gastroenterology
